Development of red blood cell-derived extracellular particles as a biocompatible nanocarrier of microRNA-204 (REP-204) to harness anti-neuroblastoma effect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of red blood cell-derived extracellular particles as a biocompatible nanocarrier of microRNA-204 (REP-204) to harness anti-neuroblastoma effect

Published:2024-08 Issue: Volume:60 Page:102760
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Chiangjong Wararat,Panachan Jirawan,Keadsanti Sujitra,Newburg David S.,Morrow Ardythe L.,Hongeng Suradej,Chutipongtanate Somchai

Publisher

Elsevier BV

Reference61 articles.

1. Extracellular vesicle-based method for detecting MYCN amplification status of pediatric neuroblastoma;Panachan;Cancers (Basel),2022

2. MYCN impact on high-risk neuroblastoma: from diagnosis and prognosis to targeted treatment;Bartolucci;Cancers (Basel),2022

3. Development of differentiation modulators and targeted agents for treating neuroblastoma;Jin;Eur J Med Chem,2020

4. Neuroblastoma: biological insights into a clinical enigma;Brodeur;Nat Rev Cancer,2003

5. The international neuroblastoma risk group (INRG) staging system: an INRG task force report;Monclair;J Clin Oncol,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP